With a special interest in Melanoma Surgery, he is also a researcher whose interests include anti-tumour immune response in human malignancies, tumour Immunology and cancer vaccine treatments.
Results of Prof Coventry et al research paper, pub 2014 titled “Vaccinia Melanoma Cell Lysate Vaccine (VMCL) Trial for treatment of advanced Stage IV Melanoma with and without Chemotherapy”, in collaboration with Professor Peter Hersey; captured the attention of medical and scientific community.
Trial conclusions reported “relatively high complete response rates, useful clinical responses & long term survival with little toxicity”. Prof Coventry with colleague Martin Ashdown, has an active interest in timing of therapy in association with cancer vaccines.
Return to Home – for more uplifting Cancer Podcasts – Grace Gawler & Guests